Norwegia -
Norwegia -
Statens legemiddelverk
pirfenidone sandoz 801 mg
sandoz - københavn - pirfenidon - tablett, filmdrasjert - 801 mg
Norwegia -
Norwegia -
Statens legemiddelverk
pirfenidone sandoz 267 mg
sandoz - københavn - pirfenidon - tablett, filmdrasjert - 267 mg
Uni Eropa -
Norwegia -
EMA (European Medicines Agency)
recuvyra
eli lilly and company limited - fentanyl - nervesystemet - hunder - for kontroll av smerte assosiert med ortopedisk og bløtvev kirurgi hos hunder.
Uni Eropa -
Norwegia -
EMA (European Medicines Agency)
sprimeo
novartis europharm ltd. - aliskiren - hypertensjon - agenter som virker på renin-angiotensinsystemet - behandling av essensiell hypertensjon.
Norwegia -
Norwegia -
Statens legemiddelverk
lasix retard 30 mg
sanofi-aventis norge (3) - furosemid - depotkapsel, hard - 30 mg
Norwegia -
Norwegia -
Statens legemiddelverk
lasix retard 60 mg
sanofi-aventis norge (3) - furosemid - depotkapsel, hard - 60 mg
Norwegia -
Norwegia -
Statens legemiddelverk
solaraze 3 %
almirall, s.a. - diklofenaknatrium - gel - 3 %
Norwegia -
Norwegia -
Statens legemiddelverk
terbinafin hexal 250 mg
hexal a/s - terbinafinhydroklorid - tablett - 250 mg
Uni Eropa -
Norwegia -
EMA (European Medicines Agency)
paxlovid
pfizer europe ma eeig - nirmatrelvir, ritonavir - covid-19 virus infection - paxlovid is indicated for the treatment of coronavirus disease 2019 (covid-19) in adults who do not require supplemental oxygen and who are at increased risk for progressing to severe covid 19.
Uni Eropa -
Norwegia -
EMA (European Medicines Agency)
pirfenidone axunio (previously pirfenidone aet)
axunio pharma gmbh - pirfenidone - idiopatisk lungefibrose - immunsuppressive - pirfenidone aet is indicated in adults for the treatment of mild to moderate idiopathic pulmonary fibrosis (ipf).